Bebpa Inc

“No review was or will be conducted.”

“Annually, within 30 days of election to the bod each director shall complete and file a questionnaire with the secretary which discloses: a. Any compensated services by director or close relative to the corporation. B. Any such services contemplated for the upcoming year; and c. Any such services renderered or contemplated by a firm or business with which the director or close relative is associated. After disclosure of the financial interest or material facts the interested person will leave the meeting and a determination of a conflict of interest is voted on. If it is determined there is a violation the committee will notify the person and give them an opportunity to explain the alleged failure to disclose and after hearing this and making further investigation if warranted will take appropriate disciplinary and corrective action. Any member of the governing board who receives directly or indirectly any compensation is precluded from voting on matters pertaining to that compensation. Each director, principal officer and member of a committee with governing board delegated powers shall annually sign a statement which affirms such person received a copy of the conflict of interest policy, read and understands the policy, agrees to comply with the policy and understands the rules and limitations imposed upon the organization as a charitable organization to maintain its federal tax exemption. Periodic reveiws will be made to ensure the above and outside experts may be used.”

“Periodic reviews are made to determine if the compensation arrangements and benefits are reasonable and in line with industry standards.”

“Periodic reviews are made to determine whether compensation arrangements and benefits are reasonable and in line with industry standards.”

“The governing documents are available for review on the website. The brochures and written information regarding the organization direct interested parties to the website.”

“Bepba provides an international forum for the presentation and discussion of scientific issues and problems encountered in the biopharmaceutical community. The aim of this open discussion is to promote development of innovative approaches and solution thus facilitating safer and faster biopharmaceutical product development.”

“Establishing, reviewing and governing recurrent scientific conferences.”

“Taxes 0 327 0 direct conference expenses 1,057 0 0 eub meeting expenses 179,351 0 0 hcp meetin expenses 128,529 0 0 special topic workshops 4,467 0 0 usb meeting expenses 91,435 0 0 total 404,839 327 0”